| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 26 May 2026 | 20 May 2026 |
| JHS Svendgaard Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 inter alia to consider and approve Audited Financial Results for the Quarter and Year Ended 31st March 2026 The Board of Directors of the company inter alia, considered and approved the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2025 today in its Board Meeting dated May 26, 2026. (As per BSE Announcement dated on: 26.05.2026) | ||
| Board Meeting | 10 Feb 2026 | 4 Feb 2026 |
| JHS Svendgaard Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 inter alia to consider and approve the un-audited financial result for quarter and nine months ended 31 December 2025. The Board of Director Considered and approved the Un-Audited Financial Results for the Quarter Ended 31st December, 2025 (As Per BSE Announcement Dated on: 10/02/2026) | ||
| Board Meeting | 1 Feb 2026 | 1 Feb 2026 |
| The Board of Directors at their meeting held on 01st February, 2026 approved the allotment of 1801801 equity shares at an issue price 27.75 through conversion of warrants | ||
| Board Meeting | 14 Nov 2025 | 7 Nov 2025 |
| JHS Svendgaard Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 inter alia to consider and approve un-audited Financial results for the quarter and half year ended September 30 2025. JHS Svendgaard Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve un-audited financial results for the quarter and half year ended September 30, 2025. (As Per BSE Announcement Dated on 10-11-2025) Financial Results for the Quarter and Half year ended 30th September, 2025 (As Per BSE Announcement Dated on: 14/11/2025) | ||
| Board Meeting | 21 Aug 2025 | 18 Aug 2025 |
| JHS Svendgaard Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/08/2025 inter alia to consider and approve the JHS Svendgaard Laboratories Employee Stock Option Scheme - 2025 (Scheme). The Board of Directors have approved the JHS Svendgaard Laboratories Employee Stock Options Scheme-2025 in its meeting held on 21st August, 2025. (As Per BSE Announcement Dated on: 21/08/2025) | ||
| Board Meeting | 12 Aug 2025 | 7 Aug 2025 |
| JHS Svendgaard Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 inter alia to consider and approve Un-Audited Financial Results for the Quarter Ended 30th June 2025 and Employee Stock option plan The Board of Directors in their meeting held today i.e. 12 August, 2025 approved and recommended M/s Dahiya & Associates, PCS Firm as an Secretarial Auditor of the company and M/s V.K. Khosla & Co. as an Statutory Auditor of the Company. The Board of Director in their meeting held today i.e. 12 August, 2025 has considered and approved the Un-Audited Financial Result for the quarter ended 30th June, 2025. The Board of Directors in their meeting held today i.e. 12 August, 2025 has considered and approved the Un-Audited Financial Result for quarter ended 30th June, 2025. (As per BSE Announcement Dated on 12/08/2025) | ||
| Board Meeting | 1 Jul 2025 | 1 Jul 2025 |
| Outcome of the Board Meeting held on July 01, 2025, re-appointment of Mr. Nikhil Nanda as Managing Director and considered the completion of tenure/cessation of Mr. Mukul Pathak as an Independent Director of the Company. | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
